Back
EyePoint Pharmaceuticals Stock Predictions

Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
EYPT
EyePoint Pharmaceuticals
Last Price:
$6.49
Seasonality Move:
10.98%
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Space Move Could Send This Pre-IPO Stock Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.EyePoint Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically risen by 35.8% based on the past 20 years of stock performance.
-
EyePoint Pharmaceuticals has risen higher in 6 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
-
Is EyePoint Pharmaceuticals Stock Undervalued?The current EyePoint Pharmaceuticals [EYPT] share price is $6.50. The Score for EYPT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
EYPT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will EyePoint Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically risen by 35.8% based on the past 20 years of stock performance.
EyePoint Pharmaceuticals Stock Rating
Sell
14
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals overpriced?
-
EyePoint Pharmaceuticals has risen higher in 6 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
EyePoint Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
eyepointpharma.com
52-Week Data
52-Week High:
29.45
52-Week Low:
5.90
Prediction Charts
Market Cap:
443.6M
Price in USD:
6.50
Volume:
476.9K
Beta:
1.87
Technical Analysis
SMA50:
7.70
SMA100:
8.74
SMA200:
9.28
52-Wk Change:
-77.52%
Stock Predictions
-
Is EyePoint Pharmaceuticals stock public?Yes, EyePoint Pharmaceuticals is a publicly traded company.
-
What is the EyePoint Pharmaceuticals stock quote today?The EyePoint Pharmaceuticals stock price is 6.50 USD today.
-
How to buy EyePoint Pharmaceuticals stock online?You can buy EyePoint Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jan-28 | 8.03 | 7.83 | 8.18 | 7.70 |
Jan-29 | 7.83 | 7.73 | 8.02 | 7.58 |
Jan-30 | 7.85 | 8.05 | 8.16 | 7.77 |
Jan-31 | 8.04 | 7.65 | 8.14 | 7.58 |
Feb-3 | 7.45 | 7.17 | 7.54 | 7.12 |
Feb-4 | 7.19 | 7.62 | 7.87 | 7.11 |
Feb-5 | 6.62 | 7.80 | 8.68 | 6.55 |
Feb-6 | 7.81 | 6.62 | 7.82 | 6.60 |
Feb-7 | 6.86 | 6.50 | 6.99 | 6.35 |
Feb-10 | 6.54 | 6.27 | 6.67 | 5.90 |
Feb-11 | 6.18 | 6.28 | 6.47 | 5.95 |
Feb-12 | 6.19 | 6.35 | 6.44 | 6.03 |
Feb-13 | 6.38 | 6.31 | 6.52 | 6.20 |
Feb-14 | 6.34 | 6.50 | 6.66 | 6.30 |
EyePoint Pharmaceuticals Earnings
EyePoint Pharmaceuticals Earnings Report: Per Share EyePoint Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
EyePoint Pharmaceuticals Forecast Revenue Growth
EyePoint Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for EyePoint Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and a decrease next year of $0.28 per share.
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.